Skip to content
<
>

Amy Herzog’s adaptation of ‘An Enemy of the People’ is now available to license through Concord Theatricals

Herzog’s adaptation of the Henrik Ibsen classic received a 2024 Tony Award nomination.

Jeremy Strong in “An Enemy of the People” on Broadway, 2024 (Credit: Emilio Madrid)

Concord Theatricals has acquired the exclusive, global licensing rights to Amy Herzog’s adaptation of Henrik Ibsen’s “An Enemy of the People.” The Tony Award-nominated version is now available for licensing through Samuel French, an imprint of Concord.

“I’m thrilled to be teaming up with Concord Theatricals again on my second Ibsen adaptation, ‘An Enemy of the People,’” Herzog said in a statement. “Working on Ibsen’s classic play, I was gobsmacked by its relevance to our contemporary politics. I’d love to see this great old play embraced by the next generation of theater makers here in the U.S. and internationally, and I’m grateful that Concord will bring the play to new audiences.” 

“Amy is the rare dramatist who can spar with the classics and make the result feel like a work that’s truly her own. This adaptation offers an electrifying take on this well-known play that will move contemporary audiences,” added Amy Rose Marsh, vice president of acquisitions and artistic development at Concord. “For theaters, this is a timely choice of material, as we, as a society, wrangle with the challenge of misinformation.”

In the Norwegian-set “An Enemy of the People,” doctor Thomas Stockmann discovers the waters of the popular new spa are contaminated. His efforts to make the news public are challenged by those in power, namely his brother, the town’s mayor, Peter Stockmann. Directed by Sam Gold and starring Jeremy Strong and Michael Imperioli, “An Enemy of the People” opened on Broadway on March 18 and played an extended limited engagement through June 23. The production received five Tony Award nominations, including a nod for Best Revival of a Play. Strong took home the trophy for his star turn as Doctor Stockmann.

“An Enemy of the People” marks Concord’s second acquisition of a Herzog-adapted Ibsen drama, having acquired the licensing rights to the 2023 Tony-nominated version of “A Doll’s House.” Additionally, Herzog’s “Mary Jane” (which played Broadway simultaneously with “Enemy”), “Belleville” and “4000 Miles” are available for licensing from Concord. 

In addition to Samuel French, Concord’s licensing house encompasses R&H Theatricals, Tams-Witmark and the Andrew Lloyd Webber Collection.